Additionally, biologics, i.e., IL-17 inhibitors and IL-12/23 inhibitors, which are commonly used among patients with inflammatory-autoimmune diseases such as psoriasis and inflammatory bowel diseases (IBD), may predispose to mycotic infections [11,12]. The gene discussed is IL17A; the disease is inflammatory bowel disease.